Table 12.6b

Immunosuppression Used for Maintenance Prior to Discharge, 1994 to 2003

Recipients with Lung Transplants

		Year of Transplant
		1994	1995	1996	1997	1998	1999	2000	2001	2002	2003
Functioning Graft at Discharge		643	775	704	808	756	804	861	957	951	1,019
With Immunosuppression Info		637	763	636	802	753	792	855	953	946	1,012
Corticosteroids	Category Usage	98.1%	97.2%	97.0%	98.6%	97.3%	98.1%	97.7%	99.0%	98.5%	94.6%
	Steroids	98.1%	97.2%	97.0%	98.6%	97.3%	98.1%	97.7%	99.0%	98.5%	94.6%
Cyclosporine	Category Usage	92.2%	76.9%	70.6%	74.6%	73.4%	66.5%	61.9%	51.4%	42.3%	34.2%
	Cyclosporin	88.2%	60.8%	2.2%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
	Sandimmmune	3.8%	13.2%	19.3%	16.8%	11.8%	10.9%	6.9%	5.7%	4.5%	4.7%
	Neoral	0.5%	4.5%	50.2%	59.9%	63.6%	59.3%	56.0%	40.5%	32.2%	23.6%
	Gengraf	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	1.1%	6.2%	7.3%	7.7%
	Eon	0.0%	0.0%	0.0%	0.0%	0.0%	0.1%	0.0%	0.4%	0.1%	0.1%
Tacrolimus	Category Usage	5.2%	9.0%	21.2%	24.7%	26.6%	30.2%	38.4%	49.5%	57.2%	65.6%
	FK506	5.2%	9.0%	21.2%	24.7%	26.6%	30.2%	38.4%	49.5%	57.2%	65.6%
Antimetabolites	Category Usage	96.2%	90.7%	90.1%	90.8%	92.2%	91.8%	93.6%	91.7%	90.9%	89.5%
	Azathioprine	95.8%	87.4%	80.5%	71.9%	70.0%	63.9%	57.8%	50.3%	45.7%	46.0%
	Mycophenolate mofetil	0.3%	3.7%	11.3%	20.8%	23.8%	29.2%	36.3%	42.3%	46.1%	44.6%
	Leflunomide	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.1%	0.1%	0.0%	0.0%
	Cytoxan	0.3%	0.1%	0.0%	0.4%	0.1%	0.4%	0.4%	0.1%	0.3%	0.0%
Other	Category Usage	0.0%	0.0%	0.0%	0.1%	0.1%	0.6%	2.6%	4.2%	1.9%	1.1%
	Rapamycin	0.0%	0.0%	0.0%	0.1%	0.1%	0.6%	2.6%	4.2%	1.9%	1.1%

Source: OPTN/SRTR Data as of May 3, 2004.

Individual drug percentages will not necessarily add up to the drug category percentages, as patients may

be prescribed more than one drug within the same category.